Press Releases
Sales of $631 million, up 7 percent from the prior-year quarter Net income (including discontinued operations) of $57 million, or $1.04 per diluted share Income from continuing operations of $60 million, or $1.09 per diluted share Adjusted income from continuing operations excluding intangibles
WILMINGTON, Del., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has been named among the 100 Best ESG Companies by Investor’s Business Daily (IBD). The recognized companies of 2022 include a combination of profitability with environment, social and governance (ESG) responsibility.
WILMINGTON, Del., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has been recognized with the Commitment to Life Award in the Human Rights category by Natura&Co for Ashland’s Responsible Solvers ™ sustainable guar farming and education program using science, technology, engineering, and
WILMINGTON, Del., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has earned EcoVadis Gold underscoring the company’s commitment to environment, social and governance (ESG) and a conscious-to-cutting-edge approach to innovation. Since its founding in 2007, EcoVadis, one of the world’s
New product to be featured in interactive innovation zones within company booth 3755 during SupplySide West tradeshow
11/01/2022
WILMINGTON, Del., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research Office of New Drugs has accepted Ashland Viatel ™ bioresorbable mPEG-PDLLA pharmaceutical excipient in the review
10/26/2022
WILMINGTON, Del., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter earnings release at approximately 5 p.m. ET on Monday, November 7, 2022. The company’s live webcast with securities analysts will include an executive summary and detailed
Company charts significant progress across all three pillars, demonstrating its transformation strategy, enhanced innovation portfolio and multi-regional business focus while delivering on emissions reduction, community engagement, environment and anti-corruption goals WILMINGTON, Del., Oct.
Wilmington, Del., Oct. 3, 2022 - Ashland is introducing Klucel™ xtend hydroxypropyl cellulose (HPC) controlled release matrix former, designed to deliver unsurpassed process versatility and release profile efficiency. It is the latest addition to the company’s Klucel™ product line and further